( RICS:ORMP )

News from Oramed Pharmaceuticals Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Mar 22, 2017, 08:45 ET Oramed to Present at Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference on March 28, 2017

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...


Mar 21, 2017, 08:45 ET Oramed Appoints Dr. Ronald Law as Chief Strategy Officer

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a developer of oral drug delivery systems, announced today the appointment of Dr....


Feb 07, 2017, 08:30 ET Oramed to Present at BIO CEO and Investor and Disruptive Growth and Healthcare Conferences

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...


Nov 29, 2016, 08:30 ET Oramed's ORMD-0901 (Oral GLP-1 Analog) Found Safe and Well Tolerated in Phase Ib Study

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a developer of oral drug delivery systems, today announced it successfully concluded a...


Oct 06, 2016, 08:45 ET Oramed Receives Additional $4 Million Milestone Payment From HTIT

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, today announced it has received an...


Sep 19, 2016, 09:00 ET Oramed to Present at the Aegis Capital Growth Conference

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of...


Sep 07, 2016, 08:00 ET Oramed to Present at the Rodman & Renshaw Global Investment Conference

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...


Aug 02, 2016, 09:00 ET Oramed Receives Additional $4 Million Milestone Payment From HTIT

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, today announced it has received a...


Jul 28, 2016, 08:15 ET Oramed Reports Additional Phase IIb Oral Insulin Study Data Demonstrating Significant Lowering of Glucose Levels vs Placebo

Statistically Significant Results Across Key Glycemic Endpoints  Conference Call Today at 11:00 AM ET  Oramed Pharmaceuticals Inc....


Jul 26, 2016, 09:00 ET Oramed Appoints Dr. Roy Eldor as Chief Medical Director

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today the appointment of...


Jun 21, 2016, 09:05 ET Oramed Announces $6.5 Million Milestone Payment from HTIT

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a developer of oral drug delivery systems, today announced that Hefei Tianhui...


Jun 09, 2016, 08:15 ET Oramed to Present at the American Diabetes Association 76th Scientific Sessions

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...


May 18, 2016, 07:25 ET Oramed Announces Positive Top-Line Results from Phase IIb Oral Insulin Study

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), today announced positive top-line results from its Phase IIb study, designed to evaluate the safety...


May 11, 2016, 08:15 ET Oramed Patent Being Granted in China for Oral Administration of Proteins

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that an official...


Apr 28, 2016, 08:15 ET Oramed to Present at PIONEERS 2016, Presented by Joseph Gunnar

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...


Feb 04, 2016, 08:15 ET Oramed to Present at the BIO CEO & Investor Conference

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...


Jan 06, 2016, 08:15 ET Oramed Pharmaceuticals' Shareholder Letter

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), today issued the following shareholder letter: Dear Shareholders,  2015...


Dec 29, 2015, 08:15 ET Oramed Announces Closing of Licensing and Investment Deal with HTIT for Oral Insulin Capsule in China

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, today announced the closing of its...


Nov 30, 2015, 08:16 ET Oramed Signs up to $50 Million Licensing and Investment Agreements for Oral Insulin Capsule in China

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems,...


Oct 01, 2015, 08:15 ET Oramed to Present at the Aegis Capital Growth Conference

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...


Sep 09, 2015, 08:15 ET Oramed Completes Randomization of Over 50% of Patients in Phase IIb Oral Insulin Study

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...


Sep 04, 2015, 08:15 ET Oramed to Present at the Rodman & Renshaw Global Investment Conference

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...


Feb 05, 2015, 08:25 ET Oramed to Present at the BIO CEO & Investor Conference

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...


Jan 28, 2015, 09:00 ET Oramed Pharmaceuticals Inc. Issues Letter to Shareholders

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), Dear Friends, Shareholders and Associates,  As we recently entered into...


Jan 16, 2015, 08:25 ET Oramed Granted Patent in Israel for Oral Administration of GLP-1

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...